Bluejay Diagnostics (BJDX) Non-Current Assets (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Non-Current Assets of $1.6 million for Q1 2026, down 1.48% sequentially from $1.7 million in Q4 2025, and down 4.38% YoY from $1.7 million in Q1 2025.
Bluejay Diagnostics (BJDX) Non-Current Assets (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Non-Current Assets for 7 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Non-Current Assets fell 4.38% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (down 8.63% YoY) and the FY2025 annual result came in at $1.7 million, down 5.85% from the prior year.
- Non-Current Assets fell to $1.6 million in Q1 2026 per BJDX's latest filing, from $1.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $2.0 million in Q1 2023 and troughed at $760675.0 in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 393.1% in 2022, then decreased 18.18% in 2024.
- Over 5 years, Non-Current Assets stood at $1.7 million in 2022, then retreated by 4.91% to $1.6 million in 2023, then rose by 6.73% to $1.8 million in 2024, then fell by 5.85% to $1.7 million in 2025, then retreated by 1.48% to $1.6 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.6 million, $1.7 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | 1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 760,675.00 |
| Dec 31, 2021 | 358,385.00 |
| Sep 30, 2021 | 358,845.00 |